Oncology News Today

Call Directions Website Contact the business

Oncology News Today The latest news and research for oncology HCPs. Sign up to our newsletter ⬇️
https://confirmsubscription.com/h/j/820ADA6F18DCD1F0

📰 NEWS: Nearly one third of patients with advanced melanoma saw tumours disappear completely after receiving TIL therapy...
26/10/2026

📰 NEWS: Nearly one third of patients with advanced melanoma saw tumours disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy

In addition, approximately two thirds (62.5 per cent) of patients in the same group saw their tumours shrink significantly, with many experiencing substantial and long-lasting responses to the combined treatment.

These findings from the IOV-COM-202 clinical trial, an international, multicentre Phase II trial conducted at The Royal Marsden NHS Foundation Trust, were presented at the 2026 ESMO - European Society for Medical Oncology Congress by Dr Andrew Furness, Consultant Medical Oncologist and Solid Tumour Cellular Therapy Lead at The Royal Marsden NHS Foundation Trust and Leader of the Cellular Therapy and Translational Immunology Group at The Institute of Cancer Research, London.

Read more: https://oncologynewstoday.co.uk/nearly-one-third-of-patients-with-advanced-melanoma-saw-tumours-disappear-completely-after-receiving-til-therapy-plus-pembrolizumab-immunotherapy/

The Royal Marsden Cancer Charity

Results from a clinical trial have revealed nearly one third of patients with advanced melanoma saw their tumours disappear completely on...

📰 NEWS: Scientists study breast milk as an early detection tool for breast cancerThe research, funded by The Christie Ch...
16/10/2026

📰 NEWS: Scientists study breast milk as an early detection tool for breast cancer

The research, funded by The Christie Charity and led by scientists at The University of Manchester, aims to transform how doctors detect breast cancer that develops during or just after pregnancy, which is often discovered late when the cancer has already spread, which leads to poorer survival rates.

Read more: https://oncologynewstoday.co.uk/scientists-study-breast-milk-as-an-early-detection-tool-for-breast-cancer/

Pictured: Dr Niki Flaum from The University of Manchester

Manchester University NHS Foundation Trust Cancer Research UK The Christie NHS Foundation Trust Prevent Breast Cancer NIHR - Health and Care Research

A pioneering new study taking place in Manchester is investigating whether breast milk could help detect breast cancer earlier than a blood test or a scan.

📰 NEWS: New research has found that a rare form of triple-negative breast cancer has a generally favourable long-term pr...
01/10/2026

📰 NEWS: New research has found that a rare form of triple-negative breast cancer has a generally favourable long-term prognosis and may not require the same treatment approach as more common triple-negative breast cancers.

The study, led by scientists at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, characterised the features, treatment patterns and long-term outcomes of adenoid cystic carcinoma (ACC) of the breast by analysing patient data over a 20-year period.

The research provides detailed long-term outcome data for an exceptionally rare form of breast cancer, for which evidence to guide treatment decisions and opportunities to conduct clinical trials are limited.

Read more:

New research has found that a rare form of triple-negative breast cancer has a generally favourable long-term prognosis and may not require the same treatment approach as more common triple-negative breast cancers.

📰 NEWS: Prostate cancer fitness programme protects men from side effects of treatment, study findsA landmark NHS trial i...
25/09/2026

📰 NEWS: Prostate cancer fitness programme protects men from side effects of treatment, study finds

A landmark NHS trial involving Sheffield Teaching Hospitals NHS Foundation Trust shows a purpose-designed prostate cancer lifestyle programme protected men from side effects of treatment, is low-cost, and can be rolled out across the NHS as a part of core prostate cancer care.

Read more: https://oncologynewstoday.co.uk/prostate-cancer-fitness-programme-protects-men-from-side-effects-of-treatment-study-finds/

The Lancet Nuffield Health Sheffield Hallam University The University of Sheffield

A landmark NHS trial involving Sheffield Teaching Hospitals NHS Foundation Trust shows a purpose-designed prostate cancer lifestyle programme protected men from side effects of treatment, is low-cost, and can be rolled out across the NHS as a part of core prostate cancer care.

📰 NEWS: More than 1,300 healthcare professionals from 113 countries learned about the latest advances in urological canc...
16/09/2026

📰 NEWS: More than 1,300 healthcare professionals from 113 countries learned about the latest advances in urological cancer treatments at the 2026 International Urology Cancer Summit

Read more:

More than 1,300 healthcare professionals from 113 countries learned about the latest advances in urological cancer treatments at the 2026 International Urology Cancer Summit.

📰 NEWS: Researchers at The Royal Marsden NHS Foundation Trust have shown that routine whole-body MRI scans could reveal ...
14/09/2026

📰 NEWS: Researchers at The Royal Marsden NHS Foundation Trust have shown that routine whole-body MRI scans could reveal far more about a patient’s health than previously thought.

Using a new artificial intelligence (AI) tool to analyse changes in muscle, body fat and organ volume, researchers found the scans could help predict how well patients with multiple myeloma respond to treatment.

Pictured: Professor Christina Messiou, Consultant Radiologist at The Royal Marsden, Professor in Imaging for Personalised Oncology at The Institute of Cancer Research, London and Chief Investigator of the study.

Read more:

Researchers at The Royal Marsden NHS Foundation Trust have shown that routine whole-body MRI scans could reveal far more about a patient's health than previously thought.

📰 NEWS: A new project funded by Cancer Research UK will explore why half of patients with a silent blood condition calle...
09/09/2026

📰 NEWS: A new project funded by Cancer Research UK will explore why half of patients with a silent blood condition called smouldering myeloma will go on to develop an incurable cancer.

There are around 6,500 new myeloma cases in the UK every year, that’s 18 every day, and is almost always preceded by earlier conditions, such as smouldering myeloma (SMM).

Although SMM itself does not generally cause symptoms, around half of patients will develop full myeloma within five years and people of African ancestry have double the risk of developing the disease.

Pictured: Project Lead Dr Elise Rees

Read more: https://oncologynewstoday.co.uk/immune-blind-spot-in-cancer-focus-of-new-study/

UCL

A new project funded by Cancer Research UK will explore why half of patients with a silent blood condition called smouldering myeloma will go on to develop an incurable cancer.

📰 NEWS: Researchers have developed a powerful new tool that has revealed surprising insights into how cells activate one...
08/09/2026

📰 NEWS: Researchers have developed a powerful new tool that has revealed surprising insights into how cells activate one of the body’s most important anti-cancer immune responses following DNA damage.

The Institute of Cancer Research

Read more:

Researchers have developed a powerful new tool that has revealed surprising insights into how cells activate one of the body’s most important anti-cancer immune responses following DNA damage.

📰 NEWS: New research has shown that more people could benefit from a new type of blood test that can predict the return ...
04/09/2026

📰 NEWS: New research has shown that more people could benefit from a new type of blood test that can predict the return of breast cancer, months before it’s picked up on a scan.

Read more:

New research funded by Breast Cancer Now has shown that more people could benefit from a new type of blood test that can predict the return of breast cancer, months before it’s picked up on a scan.

📰 NEWS: Patients in the West Midlands are among the first to benefit from the introduction of a simple and accurate new ...
03/09/2026

📰 NEWS: Patients in the West Midlands are among the first to benefit from the introduction of a simple and accurate new test for bladder cancer.

The GALEAS Bladder test requires a urine sample and can be done at home. It means many patients will avoid the necessity of an invasive cystoscopy which has to be done in a hospital and can be uncomfortable.

GALEAS Bladder has been introduced by UHCW University Hospitals Coventry and Warwickshire (UHCW) NHS Trust and is now being adopted by other West Midlands Trusts.

Pictured: Consultant Urologist Altan Omer

Read more: https://oncologynewstoday.co.uk/breakthrough-bladder-cancer-test-to-benefit-patients-in-the-midlands-first/

Address

Catherine House, Harborough Road
Brixworth
NN69BX

Alerts

Be the first to know and let us send you an email when Oncology News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Oncology News Today:

Shortcuts

Share

Nearby health & beauty businesses


Other Medical & Health in Brixworth

Show All